Mitochondrial dysfunction in Huntington’s disease C Carmo, L Naia, C Lopes, AC Rego Polyglutamine disorders, 59-83, 2018 | 182 | 2018 |
Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington’s disease models L Naia, TR Rosenstock, AM Oliveira, SI Oliveira-Sousa, GL Caldeira, ... Molecular neurobiology 54 (7), 5385-5399, 2017 | 133 | 2017 |
Histone deacetylase inhibitors protect against pyruvate dehydrogenase dysfunction in Huntington's disease L Naia, T Cunha-Oliveira, J Rodrigues, TR Rosenstock, A Oliveira, ... Journal of Neuroscience 37 (10), 2776-2794, 2017 | 62 | 2017 |
Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics L Naia, C Carmo, S Campesan, L Fão, VE Cotton, J Valero, C Lopes, ... Free Radical Biology and Medicine 163, 163-179, 2021 | 60 | 2021 |
Assessing mitochondrial function in in vitro and ex vivo models of Huntington’s disease IL Ferreira, C Carmo, L Naia, S I Mota, A Cristina Rego Huntington’s Disease, 415-442, 2018 | 26 | 2018 |
Microinjection techniques in fly embryos to study the function and dynamics of SMC complexes C Carmo, M Araújo, RA Oliveira SMC Complexes: Methods and Protocols, 251-268, 2019 | 5 | 2019 |
SIRT3, a modifier of mitochondrial function in Huntington's disease L Naia, C Carmo, S Campesan, C Lopes, J Valero, TR Rosenstock, ... Free Radical Biology and Medicine 120, S17, 2018 | 1 | 2018 |
Role of Sirtuin 3 on Mitochondrial Dynamics in Huntington's Disease Striatal Cells CSR do Carmo PQDT-Global, 2015 | 1 | 2015 |
An SNF2 helicase-like protein links mitotic transcription termination to sister chromatid resolution C Carmo, J Coelho, R Silva, A Tavares, A Boavida, P Gaetani, ... bioRxiv, 2022.11. 21.517340, 2022 | | 2022 |